Designer Babies and Genetic Enhancement
Designer Babies and Genetic Enhancement
The term “designer baby” generally refers to a child whose genetic characteristics have been selected or altered before birth. The phrase covers several distinct technologies, including preimplantation genetic testing, polygenic embryo screening, gene editing of embryos, and the possible genetic enhancement of traits such as intelligence, height, appearance, or athletic ability. Some of these methods are already used in fertility medicine, while others remain experimental, unreliable, legally restricted, or prohibited.
The debate is not simply about whether scientists can change human genes. It concerns the purposes for which genetic technologies should be used, the risks imposed on future children, the authority of parents and governments, and the social consequences of defining some traits as more desirable than others. Supporters emphasize the potential to prevent severe inherited diseases. Critics warn about safety, inequality, disability discrimination, commercialization, genetic determinism, and the reappearance of eugenic ideas through consumer choice.
From Genetic Testing to Genetic Design
Reproductive genetic technologies exist along a spectrum. Established forms of preimplantation genetic testing can identify embryos affected by certain chromosomal abnormalities or single-gene disorders. Parents using in vitro fertilization may then decide which embryo to transfer. Although this process does not alter DNA, it selects among embryos according to genetic information.
Polygenic embryo screening attempts to estimate the likelihood of complex conditions and traits influenced by many genetic variants. Companies have promoted screening for risks involving diabetes, heart disease, cancer, and psychiatric conditions. Some services have also claimed that genetic information could help predict height, intelligence, or educational attainment.
Embryo gene editing would go further by directly changing DNA. CRISPR and newer techniques such as base editing and prime editing can make increasingly precise alterations. However, editing embryos intended for reproduction could introduce changes inherited by subsequent generations. This makes germline editing fundamentally different from treatments affecting only the individual patient.
The CRISPR-Babies Experiment
The international debate changed dramatically in November 2018 when Chinese scientist He Jiankui announced the birth of genetically edited twins. He said he had altered the CCR5 gene in an attempt to provide resistance to HIV. Scientists and ethicists widely condemned the experiment because it lacked a compelling medical justification, exposed the children to uncertain risks, and proceeded without adequate ethical oversight or informed consent.
Investigations found serious problems with the experiment’s design, authorization, and participant protections. He Jiankui was subsequently convicted of illegal medical practice and sentenced to prison. The episode demonstrated that the technical ability to edit embryos could develop faster than effective international governance.
The experiment also revealed the limitations of voluntary scientific restraint. Statements from professional organizations and international summits had discouraged reproductive germline editing, but these declarations did not prevent an individual researcher from proceeding. He Jiankui’s later return to laboratory research renewed concerns about accountability and the possibility of additional attempts to create gene-edited children.
Scientific Risks of Embryo Editing
Embryo editing remains scientifically unpredictable. CRISPR can produce unintended mutations, large deletions, chromosomal rearrangements, or changes outside the intended genetic target. Mosaicism may occur when some cells carry the alteration while others do not. An edited child could therefore experience unexpected medical consequences that might not become apparent until later in life.
Heritable alterations would also affect people who could not consent to the procedure, including the resulting child and potentially that child’s descendants. Errors introduced into the germline might become difficult or impossible to reverse. Researchers would need to demonstrate extraordinary levels of accuracy and safety before reproductive use could be considered.
The clinical need for germline editing is also disputed. In many situations, prospective parents at risk of transmitting a genetic disorder can use existing alternatives, including embryo testing, donor eggs or sperm, adoption, or prenatal testing. Cases in which every viable embryo would inherit a serious condition may be comparatively rare.
Therapy Versus Enhancement
A central ethical question is whether genetic intervention should be limited to treating or preventing disease. Correcting a mutation responsible for a severe childhood disorder may appear morally different from increasing height or attempting to improve intelligence. Public opinion surveys generally show greater support for medical uses than for enhancement.
The boundary between therapy and enhancement is nevertheless difficult to define. A genetic change that protects against disease might also improve performance or longevity. Definitions of normal health vary across cultures, historical periods, and social environments. A trait classified as a disorder in one context may be regarded as a valuable form of human difference in another.
Supporters of enhancement argue that medicine, education, nutrition, and technology already improve human abilities. From this perspective, genetic enhancement may be another way for parents to promote their children’s well-being. Critics respond that permanent biological design differs from providing opportunities that children can later accept, reject, or reinterpret.
Polygenic Embryo Screening
Polygenic scores combine information from numerous genetic variants to estimate statistical risks or tendencies. These scores may identify patterns across large populations, but they cannot reliably determine the future health, intelligence, personality, or accomplishments of a particular child.
Embryos from the same parents share much of their genetic material. Consequently, selecting the embryo with the highest score may produce only a small average difference. The embryo predicted to be tallest or most intelligent will not necessarily develop that trait because complex characteristics are shaped by environmental conditions, family circumstances, education, development, chance, and interactions among genes.
Polygenic predictions can also be less accurate for populations poorly represented in genetic databases. Many scores were developed using data predominantly obtained from people of European ancestry. Applying them to other populations may produce misleading estimates and deepen health disparities.
Despite these limitations, commercial embryo-ranking services have expanded. Some prospective parents have reportedly sought predictions involving intelligence, height, and disease risk. This commercialization may encourage parents to treat uncertain statistical estimates as guarantees and to evaluate embryos according to socially preferred characteristics.
Parental Choice and the Future Child
Reproductive freedom gives parents considerable authority over decisions concerning conception, pregnancy, and family formation. Some philosophers argue that parents have moral reasons to choose the embryo expected to have the healthiest or best life. This position is sometimes described as procreative beneficence.
Opponents reject the idea that parents are obligated to select the supposedly best child. Genetic predictions are uncertain, and definitions of the best life reflect contested cultural values. Turning embryo selection into a parental duty could create pressure to reject embryos that do not meet medical or social expectations.
Genetic design may also affect a child’s autonomy. Parents could select traits according to predetermined ambitions, potentially narrowing the child’s perceived freedom to develop an independent identity. The principle of a child’s “right to an open future” is therefore frequently applied to enhancement. At the same time, every parental decision influences a child’s opportunities, making it difficult to determine which choices improperly restrict the future.
Disability Rights and the Meaning of Disease
Disability-rights advocates have challenged the assumption that preventing the birth of people with particular conditions is equivalent to treating people who have those conditions. Embryo selection and prenatal testing can communicate that certain lives are less valuable or less worthy of social support.
The expressivist critique argues that systematically selecting against disabilities may send a harmful message to existing disabled people. Decisions presented as private reproductive choices occur within societies shaped by inaccessible environments, inadequate support, prejudice, and incomplete information about disabled lives.
The social model of disability distinguishes physical or cognitive impairments from barriers created by social institutions. A characteristic may become disabling partly because buildings, schools, workplaces, technologies, and public policies fail to accommodate human variation. From this perspective, genetic selection should not substitute for inclusion, accessibility, health care, or social support.
Others maintain that respecting disabled people does not require parents to accept every preventable medical condition. They argue that reducing pain, early death, or profound impairment can be compatible with supporting people currently living with disabilities. Ethical genetic counseling should therefore provide balanced information without directing parents toward a predetermined reproductive decision.
Eugenics and Consumer Choice
Modern reproductive genetics is frequently compared with historical eugenics. Earlier eugenic movements used sterilization, segregation, marriage restrictions, immigration controls, and institutionalization to prevent people classified as “unfit” from reproducing. These policies were associated with racism, ableism, class prejudice, colonialism, and coercive government power.
Contemporary embryo selection is usually presented as voluntary and directed by individual parents rather than the state. Nevertheless, critics argue that market incentives and social expectations could produce a decentralized or consumer form of eugenics. Fertility companies, insurers, medical professionals, and cultural standards may influence which traits parents are encouraged to select or reject.
The absence of direct government coercion does not eliminate pressure. Parents could come to believe that they are irresponsible if they decline available screening or enhancement. Traits associated with disability, difference, or social disadvantage could gradually become less accepted. Individual choices could collectively reshape the population without any centralized eugenics program.
Genetic Enhancement and Social Inequality
Advanced reproductive technologies are expensive and may initially be available primarily to affluent families. If genetic enhancement ever became effective, wealthy parents might purchase biological advantages in addition to existing advantages involving education, housing, nutrition, health care, and professional connections.
Unequal access could turn economic divisions into inherited biological divisions. Enhanced traits might become qualifications for competitive schools, employment, insurance, or social status. Families unable or unwilling to use enhancement could face discrimination, while initially optional interventions might become socially expected.
Some philosophers argue that genetic technology could instead reduce inequality by correcting inherited disadvantages. This would require policies ensuring equitable access and preventing discrimination. Whether enhancement reduces or deepens inequality would therefore depend on the technology, the traits targeted, the distribution system, and the broader political and economic environment.
Commercialization and the Commodification of Children
The fertility industry increasingly markets genetic information directly to prospective parents. Commercial services may portray embryo screening as a way to choose healthier or more successful children. Promotional claims can exceed the scientific evidence, particularly when they concern complex traits.
The commodification objection holds that selecting and purchasing desired characteristics may encourage parents to regard children as designed products. Parents could judge a child against promised genetic outcomes or feel disappointed when development does not match a prediction.
Defenders respond that parents already spend substantial resources trying to improve their children’s prospects. Paying for genetic testing does not necessarily prevent unconditional love. The ethical concern arises when commercial markets exaggerate control, exploit parental fears, or transform social preferences into genetic standards.
Governance, Law, and Human Rights
International organizations have repeatedly called for strong oversight of human genome editing. The World Health Organization has recommended global registries, transparency, public engagement, international coordination, and safeguards against unsafe or unethical practices. Scientific organizations generally maintain that reproductive germline editing is not ready for clinical use.
National laws vary considerably. Some jurisdictions permit laboratory research on embryos under strict conditions but prohibit implantation. Others restrict embryo research more broadly or lack legislation specifically addressing new gene-editing methods. These differences create concerns about medical tourism and researchers moving controversial activities to countries with weaker oversight.
Human-rights frameworks emphasize dignity, equality, informed consent, privacy, and nondiscrimination. The Council of Europe’s Oviedo Convention prohibits genetic interventions intended to affect descendants. UNESCO’s declarations connect the human genome with the common heritage of humanity and warn against discrimination based on genetic characteristics.
Governance must extend beyond scientific experts. Decisions about heritable alteration affect future generations and could transform social understandings of health, disability, parenthood, and equality. Legitimate policy therefore requires continuing participation by patients, disabled people, families, religious communities, social scientists, ethicists, and the broader public.
Public Opinion, Culture, and Religion
Public attitudes toward reproductive genetics depend heavily on purpose. Many people distinguish between preventing a severe disease and enhancing intelligence, athletic ability, or appearance. Support also varies according to perceived safety, fairness, religious belief, trust in institutions, and concern about government or corporate control.
Religious traditions offer diverse perspectives. Some emphasize healing, stewardship, and the moral value of preventing suffering. Others warn against pride, excessive control over creation, the commodification of life, or attempts to redesign human nature. Religious objections cannot be reduced to a single accusation that scientists are “playing God.”
Popular culture strongly influences the debate. The film Gattaca depicts a society divided according to genetic status and remains a common reference point for concerns about designer babies. Such cultural narratives can illuminate possible social dangers, although they may also exaggerate the degree of control scientists have over complex human traits.
The Myth of Genetic Perfection
The idea of a genetically perfect child rests on an overly deterministic understanding of human development. Genes influence health and behavior, but they do not function as fixed blueprints. Intelligence, personality, talent, and achievement emerge through interactions among many genes, family environments, education, nutrition, culture, opportunity, chance, and personal experience.
A genetic variant may have different effects in different environments. Selecting one characteristic may unintentionally influence another because individual genes and polygenic scores can be associated with multiple outcomes. Social definitions of desirable traits also change over time.
The phrase “designer baby” can therefore mislead by suggesting that parents will be able to select children’s characteristics with the precision of choosing product features. The technology’s actual capabilities are much more limited. Nevertheless, the social consequences of even imperfect prediction and selection may still be significant.
Future Possibilities and Long-Term Risks
Base editing and prime editing may eventually permit more precise genetic changes than conventional CRISPR. Advances in genome sequencing, artificial intelligence, reproductive medicine, and laboratory production of eggs or sperm could also increase the number of embryos available for screening.
Greater technical precision would not resolve every ethical question. A safe intervention could still promote discrimination, intensify inequality, restrict a child’s autonomy, or encourage coercive social expectations. Conversely, ethical concerns should not obscure the possibility that carefully governed genetic therapies could prevent severe suffering.
Long-term risks include irreversible genetic changes, loss of diversity, new forms of discrimination, commercial control of reproduction, and biological divisions between social classes. Potential benefits include preventing inherited disease, improving therapeutic knowledge, and expanding reproductive options. Responsible policy must consider both possibilities without treating technological development as either automatically liberating or inevitably dystopian.
Conclusion
Designer babies and genetic enhancement bring together rapidly developing science and longstanding questions about parenthood, medicine, justice, disability, and human difference. Existing genetic testing can help families avoid some serious inherited disorders, but polygenic predictions remain uncertain and embryo editing presents substantial technical risks.
The distinction between therapy and enhancement offers useful guidance but cannot resolve every case. Voluntary parental choice may still be shaped by markets, prejudice, inequality, and social pressure. Historical eugenics demonstrates the danger of allowing claims about genetic improvement to override dignity, equality, consent, and respect for human diversity.
Decisions about heritable genome editing should not be left solely to individual scientists, fertility companies, wealthy consumers, or national governments acting in isolation. They require transparent international oversight and broad democratic participation. The central question is not only what kinds of children technology may allow people to create, but what kind of society will receive, value, and support them.
Recent Developments and Renewed Debate
The Guardian View on Gene-Edited Humans: Darker Uses Must Be Acknowledged
| Editorial Board | The Guardian | July 5, 2026
New advances in embryo base editing revive questions about medical benefits, human enhancement, inequality, eugenics, and the creation of genetically modified children.
'There Is No Way to Stop This': The Mission to Genetically Modify Babies
| Jenny Kleeman | The Guardian | May 30, 2026
A profile of biotechnology entrepreneur Cathy Tie examines emerging commercial efforts to develop embryo editing and the renewed prospect of genetically modified babies.
World's First Personalized CRISPR Therapy Given to Baby
| Children's Hospital of Philadelphia | CHOP News | May 15, 2025
Researchers report the successful use of a customized gene-editing treatment, demonstrating the growing precision and speed of therapeutic genetic engineering.
The First Personalized Gene-Editing Treatment
| National Institutes of Health | NIH Research Matters | 2025
Doctors designed a personalized base-editing therapy for an infant with a rare disorder, illustrating capabilities that may influence future debates about prenatal genetic intervention.
WHO Issues New Recommendations on Human Genome Editing
| World Health Organization | WHO | July 12, 2021
WHO recommends international oversight, registries, public engagement, and safeguards against unsafe or unethical applications of human genome editing.
Human Genome Editing: Recommendations
| WHO Expert Advisory Committee | World Health Organization | 2021
This report proposes governance mechanisms intended to prevent irresponsible germline editing while supporting legitimate therapeutic research.
Human Genome Editing: A Framework for Governance
| WHO Expert Advisory Committee | World Health Organization | 2021
WHO presents a global governance framework addressing research oversight, medical tourism, transparency, equity, and potentially heritable genome modification.
Heritable Human Genome Editing
An international commission concludes that edited embryos should not be used for pregnancy until strict scientific and safety requirements can be satisfied.
Russian Scientist Plans More CRISPR-Edited Babies
| David Cyranoski | Nature | June 10, 2019
A Russian researcher’s proposal to create gene-edited children demonstrates how scientific competition can outpace international ethical and regulatory consensus.
China Confirms Gene-Edited Babies, Blames Scientist
| David Cyranoski | Nature | January 21, 2019
Chinese investigators confirmed that He Jiankui produced genetically edited children without adequate authorization, safety evidence, or informed consent.
The He Jiankui Experiment
Scientist Who Gene-Edited Babies Is Back in the Laboratory
| Justin McCurry | The Guardian | April 1, 2024
He Jiankui’s return to embryo research renews concerns about oversight, scientific rehabilitation, and the possibility of further attempts at heritable genome editing.
He Jiankui Sentenced to Three Years in Prison
| David Cyranoski | Nature | December 30, 2019
A Chinese court convicted He Jiankui of illegal medical practice after his unauthorized experiment produced the world’s first known gene-edited children.
The CRISPR Baby Scandal Gets Worse by the Day
| Ed Yong | The Atlantic | December 3, 2018
Further revelations about He Jiankui’s methods showed weak ethical review, questionable consent, undisclosed risks, and little medical justification.
Statement by the Organizing Committee of the Second International Summit
| Organizing Committee | National Academies | November 29, 2018
Summit organizers declare He Jiankui’s experiment irresponsible and conclude that clinical germline editing remained scientifically and ethically unacceptable.
CRISPR-Baby Scientist Fails to Satisfy Critics
| David Cyranoski | Nature | November 28, 2018
He Jiankui’s public presentation failed to resolve concerns about unintended mutations, medical necessity, participant protection, and the experiment’s secrecy.
Gene-Edited Babies: No One Has the Moral Warrant to Go It Alone
| Philip Ball | The Guardian | November 27, 2018
The author argues that decisions affecting future generations require broad democratic deliberation rather than unilateral action by individual scientists.
World’s First Gene-Edited Babies Created in China, Scientist Claims
| Staff and Agencies | The Guardian | November 26, 2018
The announcement that twin girls had been born following embryo editing prompted immediate international condemnation and demands for investigation.
Chinese Scientist Claims to Have Created Gene-Edited Babies
| Marilynn Marchione | Associated Press | November 26, 2018
The original investigative report describes He Jiankui’s attempt to alter CCR5 in embryos and the major scientific and ethical objections it generated.
CRISPR-Edited Babies Reportedly Born in China
| Dennis Normile | Science | November 26, 2018
Scientists respond to an unverified claim that genome-edited twins were born, questioning the experiment’s evidence, purpose, safety, and ethical approval.
Embryo Editing and Reproductive Technology
Scientists Use Base Editing to Study Human Embryos
| Nature News Staff | Nature | 2025
Research involving precise embryo editing illustrates both the scientific value of developmental studies and the possibility that laboratory techniques could eventually become reproductive interventions.
UK Government Urged to Consider Allowing Embryo Gene Editing
| Robin McKie | The Guardian | March 4, 2023
A citizens’ jury involving people affected by genetic disorders called for public discussion of embryo editing intended to prevent serious inherited disease.
Human Embryo Editing Gets a Road Map
| Heidi Ledford | Nature | September 3, 2020
An international report outlines scientific benchmarks that would have to be met before any country considered clinical heritable genome editing.
CRISPR Gene Editing in Human Embryos Wreaks Chromosomal Mayhem
| Heidi Ledford | Nature | June 25, 2020
Experiments found large deletions and chromosomal abnormalities after embryo editing, underscoring the technology’s unpredictability and reproductive risks.
Fear of Dystopian Change Should Not Blind Us to Gene Editing’s Benefits
| Kenan Malik | The Observer | July 21, 2018
The commentary argues that preventing genetic disease should not automatically be equated with dystopian enhancement, while acknowledging the need for social controls.
Genetically Modified Babies Given Qualified Ethical Approval
| Ian Sample | The Guardian | July 17, 2018
The Nuffield Council concluded that heritable editing might be morally acceptable if it promoted the future child’s welfare and did not increase social injustice.
Genome Editing and Human Reproduction: Social and Ethical Issues
| Nuffield Council on Bioethics | Nuffield Council on Bioethics | July 2018
This major report evaluates welfare, reproductive freedom, social justice, diversity, disability, regulation, and the possible enhancement of future children.
Correction of a Pathogenic Gene Mutation in Human Embryos
| Hong Ma et al. | Nature | August 2, 2017
Researchers reported CRISPR editing of embryos carrying a heart-disease mutation, stimulating debate over technical feasibility, embryo repair, and germline intervention.
Human Embryo Gene Editing: A Crack in the Door
| Erika Check Hayden | Nature | May 2016
The approval of embryo-editing research in Britain marked an important regulatory milestone while maintaining a prohibition against implantation and pregnancy.
Chinese Scientists Genetically Modify Human Embryos
| David Cyranoski and Sara Reardon | Nature | April 22, 2015
The first published CRISPR experiments on human embryos revealed low efficiency and unintended changes, igniting worldwide debate about germline research.
Designer Babies and Trait Selection
Polygenic Screening of Embryos Is Here, but Is It Ethical?
| Laura Hercher | Nature | March 2022
Commercial embryo screening for complex disease risks raises questions about uncertain predictions, parental choice, disability, inequality, and renewed forms of eugenics.
Screening Human Embryos for Polygenic Traits Has Limited Utility
| Todd Lencz et al. | Cell | May 13, 2021
Researchers find that embryo selection based on polygenic scores offers smaller and less certain benefits than commercial claims may suggest.
The Perils of Using Genetic Tests to Predict Children’s Intelligence
| Ewan Birney | Nature | October 2019
Predictions of intelligence from DNA remain probabilistic, population-dependent, and vulnerable to exaggeration when applied to reproductive decision-making.
A New Era of Designer Babies May Be Based on Overhyped Science
| Antonio Regalado | MIT Technology Review | May 1, 2019
Startups offering embryo ranking for complex traits may overstate what polygenic scores can reliably reveal about an individual future child.
The Polygenic Embryo Score
| Peter Kraft and Kathryn North | New England Journal of Medicine | 2018
Polygenic scores combine many genetic variants, but their predictive limits complicate attempts to rank embryos for disease risks or desirable traits.
Designer Babies: An Ethical Horror Waiting to Happen?
| Philip Ball | The Observer | January 8, 2017
Embryo production, genome sequencing, and selection may make trait-oriented reproduction possible without directly editing a child’s DNA.
The End of Sex and the Future of Human Reproduction
| Henry T. Greely | Harvard University Press | 2016
Greely predicts that laboratory-generated eggs, inexpensive sequencing, and embryo selection could transform reproduction and normalize extensive genetic screening.
The Case for Genetically Engineered Babies
| Julian Savulescu | The Guardian | May 1, 2015
Savulescu contends that fears about enhancement should not prevent carefully regulated genetic interventions that could protect future children from disease.
The Ethics of Creating Genetically Modified Children
| Robert Sparrow | Current Opinion in Pediatrics | 2015
The article considers whether parental genetic choices could harm children, reinforce social prejudices, or transform reproduction into product design.
Designer Babies: Choosing Our Children’s Genes
| Bonnie Steinbock | Nature Education | 2008
An accessible introduction explains preimplantation testing, sex selection, genetic modification, parental autonomy, and objections to selecting children’s characteristics.
Genetic Enhancement and Bioethics
Vulnerability and the Ethics of Human Germline Genome Editing
| Megan K. Labude et al. | The CRISPR Journal | 2022
The authors argue that ethical evaluations must address vulnerability, power imbalances, social marginalization, and the interests of future people.
Ethical Perspectives of Therapeutic Human Genome Editing
| Anu M. Joseph et al. | Frontiers in Genetics | 2022
A review compares philosophical, religious, and cultural perspectives on therapeutic genome editing and the boundary between treatment and enhancement.
Responsible Governance of Human Germline Genome Editing
| Yaqing Peng et al. | Asian Bioethics Review | 2022
The article identifies safety, eugenics, inequality, human dignity, and international coordination as central governance challenges.
Bioethical Issues in Genome Editing by CRISPR-Cas9 Technology
| F. B. Ayanoğlu et al. | Turkish Journal of Biology | 2020
The authors review consent, off-target mutations, heritable consequences, enhancement, equitable access, and the danger of discriminatory genetic standards.
Ethics of Human Genome Editing
| Barry S. Coller | Annual Review of Medicine | January 27, 2019
Coller distinguishes treatment from enhancement and discusses disability rights, risk, oversight, reproductive autonomy, and social consequences.
Societal and Ethical Impacts of Germline Genome Editing
| Jodi Halpern et al. | Annual Review of Genomics and Human Genetics | 2019
The article analyzes public trust, disability, social justice, responsibility to future generations, and the difficulty of governing heritable interventions.
Risks and Benefits of Human Germline Genome Editing
| Giovanni Rubeis and Florian Steger | Asian Bioethics Review | 2018
A structured assessment considers whether preventing genetic disease could justify exposing future children and subsequent generations to uncertain risks.
Human Germline Genome Editing
| Kelly E. Ormond et al. | American Journal of Human Genetics | August 3, 2017
Experts support carefully supervised laboratory research but call for extensive societal discussion before reproductive use of edited embryos.
The Ethics of Germline Gene Editing
| Christopher Gyngell, Thomas Douglas and Julian Savulescu | Journal of Applied Philosophy | 2017
The authors evaluate safety, consent, human dignity, inequality, eugenics, and possible moral arguments favoring disease prevention or enhancement.
Engineering the Perfect Baby
| Antonio Regalado | MIT Technology Review | March 5, 2015
The article anticipates how CRISPR might be applied to embryos and explores the prospect of inherited modifications and genetically enhanced children.
Therapy Versus Enhancement
Human Enhancement: Scientific and Ethical Dimensions
| National Academies of Sciences, Engineering, and Medicine | National Academies Press | 2020
Contributors consider physical, cognitive, genetic, and technological enhancement while examining fairness, identity, safety, access, and regulation.
From Therapy to Enhancement: The Ethical Debate
| Allen Buchanan and Russell Powell | Stanford Encyclopedia of Philosophy | 2020
This philosophical overview questions whether the distinction between treating disease and enhancing normal traits can support consistent public policy.
Human Genome Editing: Science, Ethics, and Governance
This landmark report recommends permitting somatic therapy while placing demanding restrictions on heritable editing and rejecting enhancement applications at present.
Genome Editing and the Future of Human Reproduction
| National Academies Committee on Human Gene Editing | National Academies Press | 2017
The chapter considers reproductive applications, serious disease prevention, enhancement, societal effects, and the conditions required for responsible clinical research.
Genetic Enhancement
| Michael J. Selgelid | Internet Encyclopedia of Philosophy | 2015
A philosophical introduction considers whether genetic enhancement differs morally from education, medicine, environmental advantages, and other parental interventions.
The Case Against Perfection
| Michael J. Sandel | Harvard University Press | 2007
Sandel argues that enhancement may undermine humility, giftedness, solidarity, and unconditional parental acceptance even when it does not directly harm anyone.
Enhancing Evolution: The Ethical Case for Making Better People
| John Harris | Princeton University Press | 2007
Harris defends some forms of genetic enhancement as an extension of medicine and a possible moral obligation to improve human well-being.
Beyond Therapy: Biotechnology and the Pursuit of Happiness
| President’s Council on Bioethics | U.S. Government | October 2003
The report examines biotechnology intended to improve performance, appearance, mood, longevity, and children rather than to cure recognizable disease.
From Chance to Choice: Genetics and Justice
| Allen Buchanan et al. | Cambridge University Press | 2000
The authors analyze genetic intervention through the principles of equal opportunity, justice, reproductive liberty, disability, and responsibility.
Eugenics, Disability, and Inequality
Human Genome Editing and the Problem of Eugenics
| Various Authors | European Journal of Human Genetics | 2021
The article examines how reproductive genetics can reproduce eugenic values even without direct government coercion or explicitly racist policies.
Genome Editing, Eugenics, and Social Justice
| Jonathan Anomaly and Christopher Gyngell | Monash Bioethics Review | 2019
The authors explore competing claims that genetic intervention could either intensify inequality or reduce biological disadvantages.
Gene Editing and the New Eugenics
| Center for Genetics and Society | Biopolitical Times | 2018
The commentary warns that consumer choice and market pressures could create a decentralized form of eugenics organized around preferred traits.
Genome Editing and Disability Rights
| Center for Genetics and Society | CGS | 2018
Disability advocates question assumptions that eliminating genetic conditions necessarily promotes justice or respects people currently living with those conditions.
The Eugenic Implications of Prenatal Testing
| Various Authors | AMA Journal of Ethics | April 2016
Prenatal selection may communicate that certain lives are less valuable, while supporters emphasize reproductive autonomy and preventing serious suffering.
Disability Rights and the New Genetics
| Erik Parens and Adrienne Asch | Hastings Center | 2015
Essays by disability scholars and bioethicists examine prenatal testing, selective abortion, parental choice, social support, and the meaning of disability.
Choosing Children: Genes, Disability, and Design
| Jonathan Glover | Oxford University Press | 2006
Glover considers whether selecting against disability or choosing advantageous traits is compatible with respect for human equality and individual difference.
The Expressivist Argument, Prenatal Diagnosis, and Disability
| Adrienne Asch | Hastings Center Report | 2000
The expressivist critique holds that selecting against disabilities can send a devaluing message about people who live with those characteristics.
Eugenics and the Welfare State
| Gunnar Broberg and Nils Roll-Hansen | Michigan State University Press | 1996
Historical studies demonstrate how reproductive control became linked to public health, welfare administration, heredity, and judgments about social worth.
In the Name of Eugenics
| Daniel J. Kevles | Harvard University Press | 1985
A comprehensive history traces eugenics from Galton through compulsory sterilization and shows why modern reproductive genetics attracts historical comparison.
Governance, Law, and Human Rights
Human Genome Editing: A Global Perspective
| World Health Organization | WHO | 2024
WHO explains the differences between somatic, germline, and heritable editing and emphasizes safety, effectiveness, ethics, and equitable governance.
Genome Editing in Human Cells: Ethical and Regulatory Issues
| Nuffield Council on Bioethics | UK Government | 2023
The review considers how existing law should respond to rapidly changing editing technologies and possible clinical reproductive applications.
Guidelines for Stem Cell Research and Clinical Translation
| International Society for Stem Cell Research | ISSCR | 2021
The guidelines establish oversight categories for embryo research and state that reproductive use of heritable genome editing remains premature.
Statement on Heritable Human Genome Editing
| International Society for Stem Cell Research | ISSCR | 2020
ISSCR calls for strong international coordination and rejects attempts to initiate pregnancies with edited embryos before scientific and ethical standards are met.
Global Observatory for Genome Editing
| Global Observatory for Genome Editing | Harvard University | 2020
This international initiative promotes inclusive discussion of genome editing beyond expert committees, incorporating cultural, social, and political perspectives.
Framework for Open, Transparent Debate on Genome Editing
| Sheila Jasanoff and J. Benjamin Hurlbut | Nature | March 2019
The authors advocate a global observatory that would broaden genome-editing governance beyond scientists and national regulators.
International Ethical Guidelines for Health-Related Research
| CIOMS | Council for International Organizations of Medical Sciences | 2016
These guidelines provide principles for consent, vulnerability, fairness, risk, community engagement, and accountability relevant to embryo-editing research.
Universal Declaration on the Human Genome and Human Rights
| UNESCO | United Nations Educational, Scientific and Cultural Organization | 1997
UNESCO identifies the human genome as part of humanity’s shared heritage and connects genetic science with dignity, equality, consent, and nondiscrimination.
Convention on Human Rights and Biomedicine
| Council of Europe | Oviedo Convention | 1997
The convention permits genome interventions for preventive, diagnostic, or therapeutic purposes but prohibits changes intended to affect descendants.
Public Opinion, Culture, and Religion
Who Should Decide the Future of Human Evolution?
| Center for Genetics and Society | CGS | 2024
The organization argues that decisions about inheritable genetic modification require inclusive democratic oversight rather than commercial or scientific control.
Americans’ Views of Gene Editing for Babies Depend on Its Purpose
| Cary Funk and Alec Tyson | Pew Research Center | March 17, 2022
Public support is substantially greater for preventing serious disease than for enhancing intelligence, athletic ability, or physical appearance.
Public Views of Human Genome Editing
| Cary Funk and Meg Hefferon | Pew Research Center | July 26, 2018
Survey respondents distinguish sharply between medical uses of embryo editing and attempts to make babies more intelligent or physically capable.
Public Engagement and Human Genome Editing
| National Academies Committee on Human Gene Editing | National Academies Press | 2017
The committee argues that transparent, continuing public participation is essential because heritable modifications affect families, communities, and future generations.
Human Genome Editing: Science, Ethics, and Public Engagement
| Royal Society | Royal Society | 2017
The project brings scientists, ethicists, policymakers, and citizens together to discuss acceptable uses and limits of genetic technologies.
The Public and Human Genome Editing
| Various Authors | Nature | 2017
Commentators emphasize that democratic legitimacy cannot be achieved through scientific expertise alone when technologies could reshape reproduction and inherited traits.
Religious Perspectives on Human Gene Editing
| David Masci | Pew Research Center | July 26, 2016
Religious traditions offer varied responses to enhancement, often emphasizing human dignity, stewardship, healing, humility, justice, and limits on technological control.
Playing God? Religious Responses to Genetic Engineering
| Ronald Cole-Turner | University of Chicago Press | 1998
The book examines theological arguments concerning creation, human responsibility, healing, parenthood, genetic control, and the accusation of “playing God.”
The Ethics of Genetic Control
| Joseph Fletcher | Cambridge University Press | 1988
Fletcher presents an early defense of reproductive genetic choice and challenges objections based on nature, divine authority, or fixed human essence.
Future Possibilities and Long-Term Risks
CRISPR Technology: A Decade of Genome Editing Is Only the Beginning
| Jennifer Doudna | Science | January 2023
Doudna reviews CRISPR’s rapid development and stresses the continuing need for responsible governance as increasingly precise editing systems emerge.
The Code Breaker
| Walter Isaacson | Simon & Schuster | 2021
A history of CRISPR and Jennifer Doudna’s work connects scientific innovation with decisions about disease treatment, germline editing, and human enhancement.
Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing
| Kevin Davies | Houghton Mifflin Harcourt | 2020
Davies chronicles the scientific discoveries, personalities, commercial competition, and ethical controversies that led to the CRISPR-babies experiment.
Prime Editing: Search-and-Replace Genome Editing
| Andrew Anzalone et al. | Nature | October 21, 2019
Prime editing can install targeted DNA changes without double-strand breaks, expanding possible therapeutic uses while adding new germline-governance questions.
Search-and-Replace Genome Editing Without Double-Strand Breaks
| Broad Institute | Broad Institute News | October 21, 2019
Researchers describe prime editing as a versatile system capable of making many precise substitutions, insertions, and deletions in DNA.
What’s Next for CRISPR Babies?
| Heidi Ledford | Nature | November 2018
Scientists consider how the birth of edited children could affect research rules, international coordination, public confidence, and future reproductive experiments.
Base Editing: Precision Chemistry on the Genome
| Alexis Komor et al. | Nature Reviews Genetics | October 2018
Base editors alter individual DNA letters without cutting both strands, potentially reducing some risks while broadening the range of possible inherited modifications.
CRISPR 2.0: Base Editing
| Holly Rees and David Liu | Nature Reviews Genetics | 2018
The review explains technologies that rewrite specific bases and considers their potential for correcting mutations more precisely than conventional CRISPR.
Human Germline Editing: The Potential for Unintended Effects
| Various Authors | Nature Methods | 2017
Unintended edits, mosaicism, incomplete biological knowledge, and multigenerational consequences make embryo modification fundamentally different from ordinary treatment.
A Crack in Creation
| Jennifer Doudna and Samuel Sternberg | Houghton Mifflin Harcourt | 2017
CRISPR pioneers explain the technology’s origins and warn that altering embryos could introduce irreversible changes into the human gene pool.
Polygenic Embryo Screening
Precautions for Polygenic Embryo Selection: Prohibition or Regulation?
| Tetsuya Ishii | Frontiers in Reproductive Health | March 5, 2026
Polygenic embryo selection is already being offered for health and intelligence predictions despite uncertainty, prompting proposals for prohibition, regulation, and continuing public oversight.
What Is Polygenic Embryo Screening in IVF, and Does It Work?
| Hannah Devlin | The Guardian | December 6, 2025
Polygenic embryo screening can estimate risks and traits, but predictions for intelligence, height, and many diseases remain uncertain and probabilistic.
UK Couples Use Loophole to Rank Embryos for IQ, Height and Health
| Hannah Devlin | The Guardian | December 6, 2025
British couples are reportedly sending embryo data abroad for polygenic analysis despite domestic restrictions on using such predictions to select embryos.
Eugenics and Polygenic Embryo Screening
| Dorit Barlevy | Genetics in Medicine | 2025
The article examines whether selecting embryos according to complex disease risks and traits promotes eugenic ideas, practices, or social expectations.
Polygenic Risk Scores and Embryonic Screening
| Christopher M. Haining et al. | Journal of Medical Ethics | 2025
The authors review the ethical challenges of polygenic embryo screening and recommend regulatory safeguards for jurisdictions considering its clinical use.
Embryo Screening and the New Eugenics
| Xavier Symons | Public Discourse | December 10, 2024
The commentary argues that selecting embryos for preferred health and nonmedical traits risks treating prospective children as products judged by genetic desirability.
Screening Embryos for Polygenic Disease Risk: A Review
| Antonio Capalbo et al. | Human Reproduction Update | 2024
The review evaluates the scientific foundations, possible benefits, limitations, clinical readiness, and reproductive implications of polygenic embryo screening.
The Use of Polygenic Risk Scores in Preimplantation Genetic Testing
| Francesca Forzano et al. | European Journal of Human Genetics | 2022
Professional geneticists warn that embryo polygenic scores lack demonstrated clinical utility and should not yet be offered as an unproven reproductive service.
Testing Embryos for IQ
| Michelle de Souza | Law, Technology and Humans | 2022
The article examines the scientific uncertainty and legal implications of predicting intelligence from embryonic DNA and selecting embryos according to those estimates.
Screening Embryos for Polygenic Conditions and Traits
| Gabriel Lázaro-Muñoz et al. | Genetics in Medicine | 2021
The authors identify concerns about clinical validity, informed consent, parental expectations, social inequality, disability, and selecting embryos for nonmedical characteristics.
Commercialization of Genetic Selection
The World’s First Gene-Edited-Baby Company Is Trying to Launch
A proposed biotechnology company illustrates continuing commercial interest in heritable genome editing despite unresolved safety, legal, and ethical objections.
The Startup Promising Healthier Babies Through Embryo Ranking
| Kristen V. Brown | Bloomberg | May 24, 2024
Fertility startups are marketing genetic predictions as tools for choosing healthier embryos, although the estimates have important scientific and ethical limitations.
The $50,000 Quest for the Perfect Baby
| Amy Dockser Marcus | The Wall Street Journal | 2024
Wealthy prospective parents are pursuing increasingly extensive embryo testing, raising concerns about consumer eugenics and unequal access to reproductive technologies.
Orchid Launches Whole-Genome Embryo Screening
| Orchid Health | Orchid | 2024
A fertility genetics company describes whole-genome embryo reports intended to estimate future disease risks before parents decide which embryo to transfer.
The Embryo Selection Industry’s New Genetic Promises
| Center for Genetics and Society | Biopolitical Times | 2023
Critics warn that commercial embryo-ranking services may exaggerate predictive power while encouraging parents to classify prospective children according to genetic desirability.
A New Era of Embryo Testing Is Already Here
| Michael Le Page | New Scientist | 2022
Fertility companies are moving beyond testing single-gene disorders toward ranking embryos for complex risks influenced by thousands of variants and environmental factors.
Polygenic Embryo Screening: Ethical and Legal Considerations
| Sonja Soni and Julian Savulescu | Hastings Bioethics Forum | October 20, 2021
The authors consider possible health benefits alongside concerns about eugenics, genetic determinism, informed consent, nonmedical selection, and inadequate regulation.
The First Baby Selected Using Polygenic Risk Scores
| Antonio Regalado | MIT Technology Review | September 17, 2021
The reported birth of a child selected partly through polygenic screening marked a controversial expansion of genetic testing in IVF.
A Company Wants to Predict Which Embryo Will Be the Smartest
| Antonio Regalado | MIT Technology Review | November 7, 2019
Commercial efforts to predict intelligence from embryo DNA demonstrate how fertility markets could introduce enhancement before the science becomes reliable.
DNA Tests for Embryos Could Create an Era of Consumer Eugenics
| Center for Genetics and Society | Biopolitical Times | 2019
The commentary argues that commercial embryo ranking may normalize socially pressured genetic selection without requiring a coercive government eugenics program.
Scientific Validity and Predictive Limits
Polygenic Embryo Screening: Four Clinical Considerations
| Patrick Turley et al. | Nature Medicine | 2022
Researchers identify limited predictive accuracy, population bias, genetic correlations, and uncertain clinical benefits as barriers to responsible embryo screening.
Utility of Polygenic Embryo Screening for Disease Depends on the Selection Strategy
| Shai Carmi et al. | eLife | May 28, 2021
The expected reduction in disease risk varies with family size, embryo number, disease prevalence, score accuracy, and the strategy used for selection.
Screening Human Embryos for Polygenic Traits Has Limited Utility
| Eyal Karavani et al. | Cell | November 21, 2019
The study estimates that embryo selection for height or intelligence would produce small average gains accompanied by substantial uncertainty.
The Accuracy of Polygenic Scores Across Global Populations
| Alicia R. Martin et al. | Nature Genetics | March 2019
Polygenic predictions developed primarily from European populations perform poorly in many other groups, creating risks of unequal and misleading reproductive applications.
The Limits of Polygenic Risk Scores
| Nicholas Wald and Robert Old | The BMJ | March 2019
The authors warn that genetic risk scores often have limited power to distinguish who will and will not develop a common disease.
The Sociogenomics of Educational Attainment
| James J. Lee et al. | Nature Genetics | July 2018
A large association study identified genetic variants connected with educational attainment, but the results are probabilistic and strongly shaped by social environments.
How Accurate Are Genetic Predictions of Intelligence?
| Saskia Selzam et al. | Molecular Psychiatry | 2018
Intelligence-associated scores explain only part of observed variation and cannot reliably determine the intellectual outcome of an individual child.
Intelligence, Height, and Behavioral Traits
Genetic Embryo Screening for Intelligence Is Premature
Predictions for intelligence remain too uncertain and context-dependent to justify ranking prospective children according to supposedly superior cognitive potential.
Can Genetics Predict a Child’s Academic Success?
| Michael Price | Science | 2022
Polygenic scores can identify statistical patterns across populations but cannot determine the educational future of a particular child.
Genetic Associations with Educational Attainment
| Andrea G. Allegrini et al. | Nature Genetics | 2022
Large genomic studies reveal associations with education while emphasizing that social conditions and family environments remain central determinants of outcomes.
Using DNA to Predict Intelligence
| Clare Wilson | New Scientist | 2021
Increasingly powerful genetic studies create pressure to use probabilistic intelligence predictions in schools, reproduction, and other sensitive settings.
Genetic Prediction of Complex Traits Within Families
| Patrick Turley et al. | Nature Genetics | 2019
Predictive scores frequently perform differently within families than across unrelated populations, complicating their use for choosing among sibling embryos.
Genome-Wide Association Study of Intelligence
| Jeanne E. Savage et al. | Nature Genetics | June 25, 2018
Researchers identified numerous genetic associations with intelligence, but these explain only a portion of variation and do not determine individual potential.
The Genetics of Intelligence
| Robert Plomin and Sophie von Stumm | Nature Reviews Genetics | January 2018
Intelligence is highly polygenic, involving many variants with extremely small effects as well as environmental and developmental influences.
Why Genes Are Not Destiny
| Kevin Mitchell | Scientific American | 2018
Developmental randomness, environment, genetic interactions, and individual experience prevent DNA sequences from functioning as fixed blueprints for personality or achievement.
Blueprint: How DNA Makes Us Who We Are
| Robert Plomin | MIT Press | 2018
Plomin emphasizes the importance of genetic differences in psychological traits, provoking debate over determinism and reproductive selection for behavioral characteristics.
Preimplantation Genetic Testing
Preimplantation Genetic Testing: Current Practices and Emerging Challenges
| American Society for Reproductive Medicine | ASRM | 2023
Professional guidance explains established testing for chromosomal abnormalities and single-gene disorders while distinguishing it from more speculative polygenic screening.
Use of Preimplantation Genetic Testing for Polygenic Disorders
| ASRM Ethics Committee | American Society for Reproductive Medicine | 2023
The committee questions whether polygenic embryo selection has sufficient evidence of clinical validity, utility, safety, and equitable application.
Preimplantation Genetic Testing for Monogenic Disorders
| ESHRE PGT Consortium | European Society of Human Reproduction and Embryology | 2020
Guidelines describe testing embryos for serious inherited disorders and the technical safeguards required before embryo transfer.
ESHRE Guideline on Good Practice in Preimplantation Genetic Testing
| ESHRE PGT Consortium | Human Reproduction Open | 2020
European specialists provide laboratory, counseling, diagnostic, quality-control, and reporting standards for established forms of preimplantation testing.
Expanded Carrier Screening and Reproductive Choice
| ACOG Committee on Genetics | American College of Obstetricians and Gynecologists | March 2017
Carrier screening can identify reproductive risks, but counseling must explain residual uncertainty and respect voluntary, informed decision-making.
Preimplantation Genetic Diagnosis and the Future Child
| Various Authors | Stanford Encyclopedia of Philosophy | 2017
Selecting embryos raises questions about parental duties, reproductive freedom, the child’s future autonomy, and whether selection harms any particular person.
Sex Selection and Preimplantation Genetic Testing
| ASRM Ethics Committee | American Society for Reproductive Medicine | 2015
Nonmedical sex selection illustrates how reproductive genetics can move from preventing disease toward satisfying parental preferences for particular child characteristics.
Embryo Screening and the Ethics of Human Genetic Engineering
| Nature Education Editors | Nature Education | 2011
This overview discusses screening embryos for diseases, disabilities, sex, and desired traits while presenting arguments for and against genetic selection.
Preimplantation Genetic Diagnosis: A Critical Review
| Karen Sermon et al. | Human Reproduction Update | 2004
The review describes early PGD technology, clinical indications, diagnostic difficulties, embryo selection, and the ethical issues created by reproductive genetic testing.
Parental Choice and Procreative Beneficence
Procreative Beneficence and Polygenic Embryo Selection
| Julian Savulescu and Jonathan Pugh | Journal of Medicine and Philosophy | 2022
The authors consider whether parents have moral reasons to choose the embryo expected to have the best opportunity for a good life.
The Moral Case for Choosing the Healthiest Embryo
| University of Oxford Bioethics Centre | Practical Ethics | 2021
Supporters argue that using reliable genetic information to reduce serious disease risk may express responsible parenthood rather than objectionable eugenics.
The Case Against Designer Children
| Françoise Baylis | Cambridge University Press | 2019
Baylis argues that heritable modification affects collective human identity and therefore cannot be treated solely as a matter of individual reproductive liberty.
Against Procreative Beneficence
| Rebecca Bennett | Journal of Medical Ethics | 2017
Bennett argues that parents are not morally required to select the supposedly best embryo and that such a duty could become oppressive.
Parental Enhancement and Children’s Autonomy
| Thomas H. Murray | Bioethics | 2014
Genetic design may change parenting by encouraging parents to view a child as a project whose characteristics should satisfy predetermined expectations.
Procreative Beneficence: Why We Should Select the Best Children
| Julian Savulescu and Guy Kahane | Bioethics | 2009
The authors defend choosing the child expected to enjoy the best life, provided the selection does not impose excessive burdens or violate other moral constraints.
Liberal Eugenics: In Defence of Human Enhancement
| Nicholas Agar | Wiley-Blackwell | 2004
Agar defends voluntary enhancement chosen by parents while attempting to distinguish liberal genetic choice from coercive state eugenics.
The Principle of Procreative Beneficence
| Julian Savulescu | Bioethics | October 2001
Savulescu proposes that prospective parents have significant moral reasons to select the possible child likely to enjoy the greatest well-being.
The Child’s Right to an Open Future
| Joel Feinberg | Princeton University Press | 1986
Feinberg’s account provides a framework for evaluating whether genetic interventions wrong children by closing off important future life choices.
Is There a Right to an Open Future?
| Joel Feinberg | Freedom and Fulfillment | 1980
The open-future principle is frequently applied to genetic enhancement because irreversible parental choices may constrain a future child’s options and identity.
Disability and the Meaning of Disease
Disability Rights Critiques of Genetic Selection
| Elizabeth Barnes | Stanford Encyclopedia of Philosophy | 2023
Philosophical accounts of disability challenge the assumption that every biological difference classified as impairment necessarily makes a person’s life worse.
Disability, Diversity, and Prenatal Selection
| Various Authors | AMA Journal of Ethics | October 2022
Ethical genetic counseling should give balanced information about disability rather than presenting termination or embryo rejection as the obvious response.
Genome Editing and Disability Justice
| Rosemarie Garland-Thomson | Hastings Center | 2020
Disability justice advocates argue that debates about eliminating genetic conditions must include people whose lives are directly characterized by those conditions.
The Disability Rights Critique of Prenatal Genetic Testing
| Stanford Encyclopedia of Philosophy | Stanford University | 2020
Critics contend that selective reproduction can reinforce discriminatory assumptions about which bodies and minds deserve social inclusion and support.
Quality of Life and Genetic Selection
| Hastings Center | Hastings Center Bioethics Briefings | 2018
Predictions about a future child’s quality of life can reflect prejudice, inaccessible environments, inadequate services, and mistaken assumptions about disability.
Is Disability a Harm?
| Elizabeth Barnes | Oxford University Press | 2016
Barnes argues that disability can constitute a valuable form of human difference rather than automatically making an individual’s overall life worse.
Disability and the Good Human Life
| Jerome Bickenbach et al. | Cambridge University Press | 2014
Essays challenge narrow concepts of normality and examine how social institutions influence whether bodily and cognitive differences become disadvantages.
Choosing Deafness for a Child
| Julian Savulescu | Journal of Medical Ethics | 2002
Debate over selecting for deafness exposes conflicts among disability identity, parental autonomy, child welfare, cultural membership, and enhancement.
The Social Model of Disability and Reproductive Genetics
| Mike Oliver | University of Leeds | 1990
The social model distinguishes bodily impairment from disabling social barriers, complicating claims that genetic selection is the best response to disability.
Enhancement, Justice, and Social Inequality
Genetic Enhancement and Economic Inequality
| Darrell M. West | Brookings Institution | 2022
Expensive reproductive technologies could allow affluent families to purchase biological advantages, reinforcing existing disparities across generations.
The Ethics of Human Enhancement
| Michael Hauskeller | Internet Encyclopedia of Philosophy | 2021
This overview examines safety, fairness, authenticity, coercion, access, disability, human nature, and the political consequences of enhancement technologies.
Enhancement Technologies and Social Justice
| Nuffield Council on Bioethics | Nuffield Council on Bioethics | 2019
Although addressing several technologies, the report’s framework for autonomy, inequality, commercialization, and social pressure applies to genetic enhancement.
Genetic Enhancement and the Distribution of Opportunity
| Colin Farrelly | Cambridge Quarterly of Healthcare Ethics | 2018
Farrelly considers whether genetic interventions might reduce natural disadvantages or instead create new hierarchies based on inherited enhancements.
Why Genetic Enhancement Could Deepen Inequality
| Various Authors | Scientific American | 2018
Access determined by wealth could transform optional genetic advantages into socially expected requirements and intensify competition among families.
Designer Babies and the Commodification of Children
| Stephen Wilkinson | Bioethics | 2010
The commodification objection asks whether choosing children’s traits encourages parents to evaluate them according to market-like standards of quality.
The Price of Perfection
| Maxwell J. Mehlman | Beacon Press | 2009
Mehlman explores how genetic enhancement might produce biological class divisions and threaten social equality, solidarity, and democratic citizenship.
Human Enhancement and Equality
| Nick Bostrom and Rebecca Roache | Oxford University | 2008
The authors consider whether access policies could distribute enhancement benefits fairly rather than prohibiting potentially valuable technologies.
Genetic Intervention and the Unfairness of Nature
| Allen Buchanan | Cambridge University Press | 2005
The book asks whether justice requires correcting inherited disadvantages or protecting people from inequalities generated by genetic technology itself.
Genes, Justice, and the Family
| Allen Buchanan et al. | Cambridge University Press | 2000
Genetic interventions must be assessed within existing inequalities involving wealth, education, health care, opportunity, and political power.
Germline Editing Risks and Alternatives
Heritable Genome Editing Is Not Ready for Clinical Use
| International Society for Stem Cell Research | ISSCR | 2023
Stem-cell researchers maintain that embryo editing for reproduction lacks adequate safety evidence, governance, public agreement, and compelling clinical justification.
Why Germline Editing Has Few Clinical Indications
| Henry T. Greely | STAT | January 28, 2019
Most couples at risk of transmitting genetic disease can produce unaffected embryos, leaving relatively few situations where editing is medically necessary.
Human Germline Editing and the Alternatives
| Paula Amato et al. | Nature Medicine | 2019
IVF, donor gametes, prenatal testing, and embryo testing can often prevent inherited disorders without introducing edited DNA into future generations.
Human Embryo Editing and the Nonidentity Problem
| César Palacios-González | Journal of Medical Ethics | 2019
Philosophical analysis asks whether selecting one embryo or editing another changes which person exists and how that affects claims of benefit and harm.
CRISPR Editing Creates Unexpected Mutations
| Allan Bradley et al. | Nature Biotechnology | July 2018
Researchers found large deletions and complex rearrangements near CRISPR target sites, highlighting risks that routine tests could overlook.
Mosaicism in CRISPR-Edited Human Embryos
| Kathy Niakan et al. | Cell Research | 2017
Embryos can contain mixtures of edited and unedited cells, making outcomes difficult to predict and potentially leaving disease-causing mutations intact.
On Human Gene Editing: International Summit Statement
| Organizing Committee | National Academies | December 3, 2015
Summit organizers state that clinical germline editing would be irresponsible until safety, ethical, and societal concerns have been adequately addressed.
Statement on Genome Editing Technologies and Human Germline Genetic Modification
| Hinxton Group | Hinxton Group | September 2015
The group supports responsible embryo research but concludes that genetically modified embryos should not be used to establish pregnancies at present.
A Prudent Path Forward for Genomic Engineering and Germline Modification
| David Baltimore et al. | Science | April 3, 2015
Scientists recommend basic research, transparent discussion, and a temporary halt to attempts to create pregnancies with genetically modified embryos.
Don’t Edit the Human Germ Line
| Edward Lanphier et al. | Nature | March 12, 2015
The authors call for restraint because inheritable editing could produce unpredictable effects, public backlash, and nontherapeutic genetic modification.
Cultural Visions of Designer Babies
Gattaca: A Film About Genetic Determinism
| National Human Genome Research Institute | NHGRI | 2022
Educational materials use the film to explore genetic discrimination, embryo selection, biological destiny, privacy, enhancement, and social inequality.
Bioethics at the Movies: Designer Babies
| National Institutes of Health | NIH Bioethics Resources | 2021
Film and literature provide accessible ways to examine how genetic selection might change parenthood, personal identity, competition, and social inclusion.
The Myth of the Perfect Genetic Child
| Various Authors | Psychology Today | 2019
Complex traits emerge from genes, development, environment, chance, and experience, making the concept of a genetically perfect child scientifically misleading.
Why the Phrase “Designer Baby” Can Mislead
The label can exaggerate scientific control over complex traits while obscuring genuine concerns about heritable modification and reproductive markets.
Gattaca Has Become a Reference Point for CRISPR Ethics
| Sarah Zhang | The Atlantic | August 2017
The film’s genetically stratified society continues to shape public fears about embryo selection and inherited biological privilege.
Building Baby from the Genes Up
| Ronald M. Green | The Washington Post | April 13, 2008
Green argues that genetic technology could prevent disease and possibly enhance human capacities, provided its development is carefully regulated.
The Meaning of Human Enhancement
| Eric Cohen | The New Atlantis | 2006
The essay examines how enhancement ambitions influence cultural understandings of achievement, dependence, giftedness, embodiment, and human limitation.
Gattaca and the Continuing Fear of Genetic Class Systems
| Philip Kitcher | Nature Genetics | 2003
Discussion of Gattaca connects reproductive genetics with discrimination, genetic social classes, employment screening, and pressure to produce optimized children.
Redesigning Humans
| Gregory Stock | Mariner Books | 2002
Stock predicts that reproductive genetics will enable parents to influence their children’s biology and argues that society must prepare for its widespread use.
Our Posthuman Future
| Francis Fukuyama | Farrar, Straus and Giroux | 2002
Fukuyama warns that biotechnology capable of altering human characteristics could destabilize equality, rights, identity, and liberal democratic institutions.
